Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-08-25

FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approves a supplemental application for glyburide by Teva Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)